Lifestyle determinants of behavioural outcomes triggered by direct-to-consumer advertising of prescription medicines: a cross-sectional study

被引:5
|
作者
Zadeh, Neda Khalil [1 ,2 ]
Robertson, Kirsten [1 ]
Green, James A. [2 ,3 ,4 ]
机构
[1] Univ Otago, Sch Business, Dunedin, New Zealand
[2] Univ Otago, Sch Pharm, POB 56, Dunedin, New Zealand
[3] Univ Limerick, Sch Allied Hlth, Limerick, Ireland
[4] Univ Limerick, HRI, Limerick, Ireland
关键词
direct-to-consumer advertising; prescription medicines; self-reported behavioural outcomes; lifestyle behaviours; New Zealand; ALL-CAUSE MORTALITY; INFORMATION-SEEKING; SOCIAL DETERMINANTS; PATIENTS REQUESTS; DISEASE RISK; HEALTH; ALCOHOL; IMPACT; INEQUALITIES; PROMOTION;
D O I
10.1111/1753-6405.12883
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: Direct-to-consumer advertising of prescription medicines encourages individuals to search for or request advertised medicines, can stimulate taking medications rather than making lifestyle behaviour changes, and may target individuals with poorer demographic and socioeconomic status and riskier health-related behaviours. This study thus explored whether responses to medicine advertising vary as a function of lifestyle behaviours, and demographic and socioeconomic factors. Methods: Data were collected through an online survey of a nationally representative sample of 2,057 adults in New Zealand. Multivariate binary logistic regressions were used to explore whether lifestyle behaviours, including nutritional habits, alcohol consumption, illegal drug consumption, physical activity, attitudes towards doing exercise, as well as demographic and socioeconomic status were associated with self-reported behavioural responses to medicine advertising. Results: Individuals who had unhealthier lifestyle behaviours were more likely to respond to medicine advertising. Conclusions: The findings raise concerns regarding the misuse or overuse of medications for diseases that may otherwise be improved by a healthier lifestyle. Implications for public health: To improve public health and wellbeing of society, we call for regulatory changes regarding advertising of medicines. Where applicable, lifestyle changes should be advertised as potential substitutes for the advertised medicines. Interprofessional collaboration is also recommended to educate individuals and convey the value of health behaviour changes.
引用
收藏
页码:190 / 196
页数:7
相关论文
共 50 条
  • [1] Direct-to-consumer advertising of prescription medicines: a counter argument
    Mintzes, Barbara
    Mangin, Dee
    FUTURE MEDICINAL CHEMISTRY, 2009, 1 (09) : 1555 - 1560
  • [2] Consumers' knowledge, perceptions, and responsiveness to direct-to-consumer advertising of prescription medicines
    Hoek, Janet
    Maubach, Ninya
    NEW ZEALAND MEDICAL JOURNAL, 2007, 120 (1249) : 60 - 69
  • [3] Time for New Zealand to ban direct-to-consumer advertising of prescription medicines
    Menkes, David B.
    Mintzes, Barbara
    Lexchin, Joel
    NEW ZEALAND MEDICAL JOURNAL, 2023, 136 (1575) : 7 - 9
  • [4] Direct-to-consumer Advertising for Urological Pharmaceuticals: A Cross-sectional Analysis of Print Media
    Folsom, Craig
    Fesperman, Susan F.
    Tojuola, Bayo
    Sultan, Shahnaz
    Dahm, Philipp
    UROLOGY, 2010, 75 (05) : 1029 - 1033
  • [5] A model for addressing stakeholders' concerns about direct-to-consumer advertising of prescription medicines
    Hoek, Janet
    Maubach, Ninya
    EUROPEAN JOURNAL OF MARKETING, 2005, 39 (9-10) : 1151 - 1165
  • [6] Strategic change within the pharmaceutical industry: The impact of direct-to-consumer advertising for prescription medicines
    Hughes-Morgan M.
    Kendrick J.L.
    Morgan F.W.
    Stoltman J.J.
    International Journal of Information Systems and Change Management, 2010, 4 (03) : 246 - 257
  • [7] Assessment of Patient Risk Profiles by a Male Sexual Health Direct-to-Consumer Prescription Platform: A Cross-Sectional Study
    von Bueren, Moritz
    Wuelfing, Christian
    Schlager, Daniel
    Traeger, Max Michael
    Daoud, Marcel
    Schroeder, Florian
    Brookman-May, Sabine D.
    Gratzke, Christian
    von Bueren, Johannes
    TELEMEDICINE REPORTS, 2023, 4 (01): : 118 - 125
  • [8] Availability and Cost of Expensive and Common Generic Prescription Drugs: A Cross-sectional Analysis of Direct-to-Consumer Pharmacies
    Lalani, Hussain S.
    Tessema, Frazer A.
    Kesselheim, Aaron S.
    Rome, Benjamin N.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (12) : 2187 - 2195
  • [9] A cross-media content analysis of motivational themes in direct-to-consumer prescription drug advertising
    Sumpradit, N
    Ascione, FJ
    Bagozzi, RP
    CLINICAL THERAPEUTICS, 2004, 26 (01) : 135 - 154
  • [10] Striving for quality use of medicines: How effective is Australia's ban on direct-to-consumer prescription medicine advertising?
    Brown, Sonja
    JOURNAL OF LAW AND MEDICINE, 2009, 16 (04) : 666 - 683